Streamline Your Market Entry with Expert Pre-Submission Support
We provides complete pre submission services to help pharmaceutical manufacturers navigate the regulatory landscape and optimize their submissions for regulatory approval, ensuring a successful outcome for pharmaceutical, biologic, medical device, or in-vitro diagnostic products
Engaging in pre-submission discussions such as FDA and other regulatory bodies is a crucial step in drug’s development, approval, commercialization, and medical device regulation. Pharmaceutical company should utilize this opportunity to present their products and regulatory plans to the FDA and health authorities, seeking their advice on the best course of action.
After reviewing an application, health authorities (HAs) may contact a sponsor or Marketing Authorization Holder (MAH) if the evidence is insufficient or further information is needed regarding efficacy, safety, and quality. This interaction underscores the proactive engagement with regulatory authorities.
Zenovel serves as a global regulatory partner for pharmaceutical companies, managing regulatory agency interactions and health authority meetings for drug development, approval, and post-approval changes. With a robust regulatory team of industry professionals and ex-agency experts, we support sponsors during agency meetings and ensure successful regulatory approval outcomes.
Enhance communication and collaboration between clients and regulatory authorities, promoting transparency, trust, and alignment throughout the submission process.
We help clients ensure your regulatory submissions meet all necessary standards and expectations, reducing the risk of non-compliance.
Tailoring regulatory strategies, navigating regulatory pathways, optimizing resource allocation, and enhancing efficiency of regulatory submission

In the pharmaceutical and biotechnology industries, obtaining regulatory approval is essential prior to introducing new drugs or biologics to the market. A pivotal aspect of this approval process is the FDA Pre-Approval Inspection (PAI), which involves a comprehensive assessment of manufacturing facilities, processes, and data integrity to ensure adherence to

Risk Based Monitoring (RBM) is a more efficient alternative to traditional clinical trials, focusing on high-risk areas through data-driven insights. It ensures patient safety, data integrity, and regulatory compliance while reducing costs and timelines. However, the success of RBM depends on the competency of monitors, who identify risks, analyze data,

Welcome to the Zenovel Blog! We are a leading provider of drug regulatory consulting and education, focusing on advancing pharmaceutical innovation while ensuring safety and compliance. This blog delves into the essentials of Drug Regulatory Affairs (DRA), covering its scope, career opportunities, and intricate processes involved in bringing new drugs

The international pharmaceutical landscape is inherently connected to the global economy and global trade, which is consisted with the quality and safety assurance , well-controlled quality and safety. Compliance with international pharmaceutical standards has changed from an optional step to a requirement. The Pharmaceutical Inspection Co-operation Scheme (PIC/S Certification) is

Lipinski’s Rule of 5 (Ro5) is a crucial guideline in pharmaceutical development, helping researchers evaluate a compound’s likelihood of becoming an effective oral drug. However, with the rapid evolution of therapeutic strategies, it’s worth considering the relevance of Ro5 in the current drug design landscape. Understanding Lipinski’s Rule of 5

Regulatory affairs (RA) play a crucial role in the pharmaceutical industry; ensuring products meet quality, safety, and efficacy. As the industry grow further the need for qualified professionals to bridge gaps between companies and regulators increases. This blog explores Zenovel regulatory affairs expertise, our various facets, and valuable contribution to
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.